These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options. Kopp R, Rothbauer E, Ruge M, Arnholdt H, Spranger J, Muders M, Pfeiffer DG, Schildberg FW, Pfeiffer A. Recent Results Cancer Res; 2003; 162():115-32. PubMed ID: 12790326 [Abstract] [Full Text] [Related]
3. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma. Song M, Kim H, Kim WK, Hong SP, Lee C, Kim H. Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420 [Abstract] [Full Text] [Related]
4. Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients. Kopp R, Ruge M, Rothbauer E, Cramer C, Kraemling HJ, Wiebeck B, Schildberg FW, Pfeiffer A. Anticancer Res; 2002 Dec; 22(2B):1161-7. PubMed ID: 12168918 [Abstract] [Full Text] [Related]
5. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. Lu Y, Jingyan G, Baorong S, Peng J, Xu Y, Cai S. Cancer Biomark; 2012 Dec; 11(5):219-26. PubMed ID: 23220854 [Abstract] [Full Text] [Related]
6. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ. J Natl Cancer Inst; 1998 Jun 03; 90(11):824-32. PubMed ID: 9625170 [Abstract] [Full Text] [Related]
7. Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors. Scambia G, Panici PB, Bellantone R, Doglietto GB, Sofo L, Ferrandina G, Ratto C, Bossola M, Crucitti F, Spagnolo LC. J Surg Oncol; 1991 Nov 03; 48(3):183-7. PubMed ID: 1943115 [Abstract] [Full Text] [Related]
8. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. Cancer; 1993 Apr 15; 71(8):2454-60. PubMed ID: 8095852 [Abstract] [Full Text] [Related]
9. Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer. Yang D, Schneider S, Azuma M, Iqbal S, El-Khoueiry A, Groshen S, Agafitei D, Danenberg KD, Danenberg PV, Ladner RD, Lenz HJ. Clin Colorectal Cancer; 2006 Nov 15; 6(4):305-11. PubMed ID: 17241515 [Abstract] [Full Text] [Related]
10. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Nakamori S, Watanabe H, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Raz A. Cancer; 1994 Oct 01; 74(7):1855-62. PubMed ID: 8082090 [Abstract] [Full Text] [Related]
11. [The association of metastasis-related indexes of lymph nodes and the prognosis of stage N2b colorectal cancer patients]. Zheng W, Zhang L, Wu YL, Zhang HZ. Zhonghua Zhong Liu Za Zhi; 2018 Sep 23; 40(9):679-683. PubMed ID: 30293393 [Abstract] [Full Text] [Related]
12. Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer. Huh JW, Kim YJ, Kim HR. Ann Surg; 2012 Jan 23; 255(1):70-8. PubMed ID: 22133895 [Abstract] [Full Text] [Related]
13. Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas. Rothbauer E, Mann K, Wiebecke B, Borlinghaus P, Lamerz R, Pratschke E, Krämling HJ, Pfeiffer A. Klin Wochenschr; 1989 May 15; 67(10):518-23. PubMed ID: 2544769 [Abstract] [Full Text] [Related]
14. A novel data-driven prognostic model for staging of colorectal cancer. Manilich EA, Kiran RP, Radivoyevitch T, Lavery I, Fazio VW, Remzi FH. J Am Coll Surg; 2011 Nov 15; 213(5):579-588, 588.e1-2. PubMed ID: 21925905 [Abstract] [Full Text] [Related]
15. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases. Karameris A, Kanavaros P, Aninos D, Gorgoulis V, Mikou G, Rokas T, Niotis M, Kalogeropoulos N. Pathol Res Pract; 1993 Mar 15; 189(2):133-7. PubMed ID: 8321742 [Abstract] [Full Text] [Related]
16. Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy. Saigusa S, Toiyama Y, Tanaka K, Inoue Y, Mori K, Ide S, Imaoka H, Kawamura M, Mohri Y, Kusunoki M. Int J Clin Oncol; 2016 Oct 15; 21(5):946-952. PubMed ID: 26919982 [Abstract] [Full Text] [Related]
17. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study. Lykke J, Jess P, Roikjaer O, Danish Colorectal Cancer Group. Dis Colon Rectum; 2015 Sep 15; 58(9):823-30. PubMed ID: 26252843 [Abstract] [Full Text] [Related]
18. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma. Funaki H, Nishimura G, Harada S, Ninomiya I, Terada I, Fushida S, Tani T, Fujimura T, Kayahara M, Shimizu K, Ohta T, Miwa K. Oncology; 2003 Sep 15; 64(4):416-22. PubMed ID: 12759540 [Abstract] [Full Text] [Related]
19. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma. Fernández-Aceñero MJ, Granja M, Sastre J, García-Paredes B, Estrada L. Virchows Arch; 2016 Apr 15; 468(4):425-30. PubMed ID: 26754675 [Abstract] [Full Text] [Related]
20. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. Deng Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E. Am J Clin Oncol; 2009 Jun 15; 32(3):245-52. PubMed ID: 19451802 [Abstract] [Full Text] [Related] Page: [Next] [New Search]